
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Period Ending | 2020-06-30 | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | |
---|---|---|---|---|---|---|
Revenue | $267.6M | $302.9M | $303.6M | $277.1M | $271.1M | |
Revenue Growth (YoY) | -2% | 13.18% | 0.25% | -8.74% | -2.17% | |
Cost of Revenues | $159.4M | $180.4M | $186.3M | $170.7M | $164.6M | |
Gross Profit | $108.2M | $122.5M | $117.3M | $106.4M | $106.4M | |
Gross Profit Margin | 40.45% | 40.44% | 38.65% | 38.41% | 39.26% | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $61.6M | $72.2M | $64.2M | $59.8M | $61.1M | |
Other Inc / (Exp) | $842.3K | -$6.2M | -$9.8M | -$182.3K | -$3M | |
Operating Expenses | $75.6M | $87.5M | $78.8M | $72.3M | $73.9M | |
Operating Income | $32.7M | $35M | $38.6M | $34.1M | $32.5M | |
Net Interest Expenses | $5.8M | $6M | $5.2M | $5.4M | $5M | |
EBT. Incl. Unusual Items | $41.4M | $38M | $38M | $41M | $37.2M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $11.9M | $11.9M | $12.5M | $12M | $11.9M | |
Net Income to Company | -- | -- | -- | -- | -- | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | $29.5M | $26.2M | $25.5M | $29M | $25.3M | |
Basic EPS (Cont. Ops) | $0.45 | $0.40 | $0.39 | $0.44 | $0.38 | |
Diluted EPS (Cont. Ops) | $0.44 | $0.39 | $0.38 | $0.43 | $0.38 | |
Weighted Average Basic Share | $66M | $66.1M | $66.3M | $66.3M | $66.3M | |
Weighted Average Diluted Share | $66.5M | $66.4M | $66.6M | $67M | $67.1M | |
EBITDA | $59.2M | $57.2M | $56M | $58M | $54.7M | |
EBIT | $45.5M | $42M | $41.5M | $45.5M | $41.9M | |
Revenue (Reported) | $267.6M | $302.9M | $303.6M | $277.1M | $271.1M | |
Operating Income (Reported) | $32.7M | $35M | $38.6M | $34.1M | $32.5M | |
Operating Income (Adjusted) | $45.5M | $42M | $41.5M | $45.5M | $41.9M |
Period Ending | 2009-12-31 | 2010-12-31 | 2011-12-31 | 2012-12-31 | 2013-12-31 | |
---|---|---|---|---|---|---|
Revenue | -- | -- | -- | -- | -- | |
Revenue Growth (YoY) | 33.63% | 21.88% | -14.41% | -6.29% | -15.13% | |
Cost of Revenues | -- | -- | -- | -- | -- | |
Gross Profit | -- | -- | -- | -- | -- | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | -- | -- | -- | -- | -- | |
Other Inc / (Exp) | -- | -- | -- | -- | -- | |
Operating Expenses | -- | -- | -- | -- | -- | |
Operating Income | -- | -- | -- | -- | -- | |
Net Interest Expenses | -- | -- | -- | -- | -- | |
EBT. Incl. Unusual Items | -- | -- | -- | -- | -- | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -- | -- | -- | -- | -- | |
Net Income to Company | -- | -- | -- | -- | -- | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -- | -- | -- | -- | -- | |
Basic EPS (Cont. Ops) | -- | -- | -- | -- | -- | |
Diluted EPS (Cont. Ops) | -- | -- | -- | -- | -- | |
Weighted Average Basic Share | -- | -- | -- | -- | -- | |
Weighted Average Diluted Share | -- | -- | -- | -- | -- | |
EBITDA | -- | -- | -- | -- | -- | |
EBIT | -- | -- | -- | -- | -- | |
Revenue (Reported) | -- | -- | -- | -- | -- | |
Operating Income (Reported) | -- | -- | -- | -- | -- | |
Operating Income (Adjusted) | -- | -- | -- | -- | -- |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Revenue | $270.7M | $290.9M | $282.7M | $270.9M | $270.8M | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $164.4M | $175.8M | $173.7M | $163M | $161.4M | |
Gross Profit | $106.3M | $115M | $109M | $107.8M | $109.5M | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $61.6M | $66.4M | $61.9M | $59.7M | $60.4M | |
Other Inc / (Exp) | -$1.1M | -$4.5M | -$2.4M | -$605.4K | $340K | |
Operating Expenses | $76M | $81.5M | $75.7M | $72.4M | $74.2M | |
Operating Income | $30.3M | $33.5M | $33.3M | $35.4M | $35.3M | |
Net Interest Expenses | $5.8M | $5.6M | $5.4M | $5.1M | $5.1M | |
EBT. Incl. Unusual Items | $37.6M | $38.2M | $39M | $42.2M | $41.9M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $10.8M | $11.2M | $11.5M | $12.5M | $12.7M | |
Net Income to Company | -- | -- | -- | -- | -- | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | $26.9M | $27M | $27.5M | $29.7M | $29.2M | |
Basic EPS (Cont. Ops) | $0.41 | $0.41 | $0.41 | $0.45 | $0.44 | |
Diluted EPS (Cont. Ops) | $0.40 | $0.41 | $0.41 | $0.44 | $0.44 | |
Weighted Average Basic Share | ||||||
Weighted Average Diluted Share | ||||||
EBITDA | $55.9M | $58.7M | $58.1M | $59.1M | $59.2M | |
EBIT | $41.7M | $43.9M | $44.6M | $46.6M | $47.8M | |
Revenue (Reported) | $270.7M | $290.9M | $282.7M | $270.9M | $270.8M | |
Operating Income (Reported) | $30.3M | $33.5M | $33.3M | $35.4M | $35.3M | |
Operating Income (Adjusted) | $41.7M | $43.9M | $44.6M | $46.6M | $47.8M |
Period Ending | 2021-07-18 | 2022-07-18 | 2023-07-18 | 2024-07-18 | ||
---|---|---|---|---|---|---|
Revenue | -- | -- | -- | -- | -- | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | -- | -- | -- | -- | -- | |
Gross Profit | -- | -- | -- | -- | -- | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | -- | -- | -- | -- | -- | |
Other Inc / (Exp) | -- | -- | -- | -- | -- | |
Operating Expenses | -- | -- | -- | -- | -- | |
Operating Income | -- | -- | -- | -- | -- | |
Net Interest Expenses | -- | -- | -- | -- | -- | |
EBT. Incl. Unusual Items | -- | -- | -- | -- | -- | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -- | -- | -- | -- | -- | |
Net Income to Company | -- | -- | -- | -- | -- | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -- | -- | -- | -- | -- | |
Basic EPS (Cont. Ops) | -- | -- | -- | -- | -- | |
Diluted EPS (Cont. Ops) | -- | -- | -- | -- | -- | |
Weighted Average Basic Share | -- | -- | -- | -- | -- | |
Weighted Average Diluted Share | -- | -- | -- | -- | -- | |
EBITDA | -- | -- | -- | -- | -- | |
EBIT | -- | -- | -- | -- | -- | |
Revenue (Reported) | -- | -- | -- | -- | -- | |
Operating Income (Reported) | -- | -- | -- | -- | -- | |
Operating Income (Adjusted) | -- | -- | -- | -- | -- |
Period Ending | 2020-06-30 | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $22.2M | $32M | $21.6M | $28.8M | $28.1M | |
Short Term Investments | -- | -- | -- | -- | -- | |
Accounts Receivable, Net | $38.5M | $41.6M | $47.7M | $39.5M | $31.4M | |
Inventory | $54.1M | $52.6M | $74.9M | $58.3M | $64M | |
Prepaid Expenses | -- | -- | -- | -- | -- | |
Other Current Assets | $2.6M | $2.2M | $2M | $2.3M | $2.8M | |
Total Current Assets | $117.9M | $129.7M | $150.2M | $129.5M | $126.5M | |
Property Plant And Equipment | $63.7M | $59.1M | $46.1M | $37.6M | $30.1M | |
Long-Term Investments | -- | $2.1M | $2M | $344.2K | -- | |
Goodwill | $46M | $50.4M | $46M | $44.5M | $44.9M | |
Other Intangibles | $243.4M | $265.6M | $241.9M | $232.4M | $234.4M | |
Other Long-Term Assets | -- | -- | -- | -- | -- | |
Total Assets | $482M | $518.5M | $492.6M | $450.3M | $441.1M | |
Accounts Payable | $30M | $38.5M | $45.4M | $30.2M | $37.7M | |
Accrued Expenses | -- | -- | -- | -- | -- | |
Current Portion Of Long-Term Debt | $18.6M | $18.8M | $13.8M | $23.2M | $23.4M | |
Current Portion Of Capital Lease Obligations | $7.9M | $8.9M | $7.7M | $7.8M | $8M | |
Other Current Liabilities | -- | -- | -- | -- | -- | |
Total Current Liabilities | $67.5M | $77.9M | $74.5M | $70.1M | $77.7M | |
Long-Term Debt | $102M | $91M | $102M | $82.1M | $68.7M | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $289.8M | $295.7M | $283.6M | $248M | $237.5M | |
Common Stock | $211.5M | $233.9M | $214.1M | $206.1M | $208.1M | |
Other Common Equity Adj | -$1.1M | $986.5K | $6.6M | $3.7M | $2.3M | |
Common Equity | $192.2M | $222.9M | $209M | $202.2M | $203.6M | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | -- | -- | -- | -- | -- | |
Total Equity | $192.2M | $222.9M | $209M | $202.2M | $203.6M | |
Total Liabilities and Equity | $482M | $518.5M | $492.6M | $450.3M | $441.1M | |
Cash and Short Terms | $22.2M | $32M | $21.6M | $28.8M | $28.1M | |
Total Debt | $120.5M | $109.8M | $115.8M | $105.3M | $92.1M |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $32.6M | $26M | $33.2M | $29.4M | $28.5M | |
Short Term Investments | -- | -- | -- | -- | -- | |
Accounts Receivable, Net | $37.1M | $33.9M | $38M | $30.7M | $19.3M | |
Inventory | $62.4M | $66.8M | $76.7M | $68.5M | $58.3M | |
Prepaid Expenses | -- | -- | -- | -- | -- | |
Other Current Assets | $4.7M | $3M | $3M | $3M | $3.1M | |
Total Current Assets | $136.7M | $132.5M | $151M | $131.6M | $110.6M | |
Property Plant And Equipment | $66.6M | $53.4M | $42M | $34.5M | $25.9M | |
Long-Term Investments | $2.2M | $2.1M | $2.1M | $358.4K | -- | |
Goodwill | -- | -- | -- | -- | -- | |
Other Intangibles | $323.3M | $304.7M | $284.7M | $284.3M | $259M | |
Other Long-Term Assets | -- | -- | -- | -- | -- | |
Total Assets | $542M | $494.6M | $485.8M | $455.1M | $398.9M | |
Accounts Payable | $37.1M | $47.8M | $38.3M | $40M | $29.8M | |
Accrued Expenses | -- | -- | -- | -- | -- | |
Current Portion Of Long-Term Debt | $32.7M | $33.6M | $31.5M | $31.7M | $28.9M | |
Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
Other Current Liabilities | -- | -- | -- | -- | -- | |
Total Current Liabilities | $86.6M | $89.1M | $77.7M | $81.9M | $64.4M | |
Long-Term Debt | $149.8M | $113.6M | $132.9M | $95.7M | $80.8M | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $321.9M | $276.5M | $281M | $246M | $208.9M | |
Common Stock | $237.1M | $225.7M | $211.8M | $212.1M | $193.6M | |
Other Common Equity Adj | -$7M | $442.2K | $1.7M | -$1.5M | -$390.5K | |
Common Equity | -- | -- | -- | -- | -- | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | -- | -- | -- | -- | -- | |
Total Equity | $220.1M | $218.1M | $204.8M | $209.1M | $190M | |
Total Liabilities and Equity | $542M | $494.6M | $485.8M | $455.1M | $398.9M | |
Cash and Short Terms | $32.6M | $26M | $33.2M | $29.4M | $28.5M | |
Total Debt | $182.5M | $147.2M | $164.4M | $127.4M | $109.7M |
Period Ending | 2020-06-30 | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -- | -- | -- | -- | -- | |
Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
Stock-Based Compensation | -- | -- | -- | -- | -- | |
Change in Accounts Receivable | -- | -- | -- | -- | -- | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | -- | -- | -- | -- | -- | |
Capital Expenditures | $8.3M | $3.8M | $1.7M | $1.5M | $2M | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | -$8.3M | -$6M | -$1.7M | -$1.5M | -$2M | |
Dividends Paid (Ex Special Dividend) | -$31M | -$16.1M | -$26M | -$25M | -$24.3M | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | $196.8M | $28.2M | $66.7M | $43.7M | $19.7M | |
Long-Term Debt Repaid | -$197.2M | -$50M | -$49.9M | -$50.5M | -$34.1M | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -$5.6M | -$6.5M | -$7.2M | -$7.6M | -$7.9M | |
Cash From Financing | -$37.1M | -$44.4M | -$16.4M | -$39.3M | -$46.6M | |
Beginning Cash (CF) | $26.6M | $24.2M | $30.9M | $21.2M | $28.5M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -$4.4M | $8M | -$8M | $8.3M | -$853.6K | |
Ending Cash (CF) | $21.7M | $31.8M | $22.8M | $29.2M | $27.5M | |
Levered Free Cash Flow | -- | -- | -- | -- | -- |
Period Ending | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | 2025-06-30 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -- | -- | -- | -- | -- | |
Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
Stock-Based Compensation | -- | -- | -- | -- | -- | |
Change in Accounts Receivable | -- | -- | -- | -- | -- | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | -- | -- | -- | -- | -- | |
Capital Expenditures | -- | -- | -- | -- | -- | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | -- | -- | -- | -- | -- | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | -- | -- | -- | -- | -- | |
Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -- | -- | -- | -- | -- | |
Cash From Financing | -- | -- | -- | -- | -- | |
Beginning Cash (CF) | -- | -- | -- | -- | -- | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -- | -- | -- | -- | -- | |
Ending Cash (CF) | -- | -- | -- | -- | -- | |
Levered Free Cash Flow | -- | -- | -- | -- | -- |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -- | -- | -- | -- | -- | |
Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
Stock-Based Compensation | -- | -- | -- | -- | -- | |
Change in Accounts Receivable | -- | -- | -- | -- | -- | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | -- | -- | -- | -- | -- | |
Capital Expenditures | $4.7M | $3.2M | $2.1M | $1.6M | $2.3M | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | -$6.7M | -$5.2M | -$2.1M | -$1.6M | -$2.3M | |
Dividends Paid (Ex Special Dividend) | -$20.2M | -$18.8M | -$26.5M | -$22.7M | -$25.9M | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | $34.2M | $26.1M | $40.5M | $23.1M | $24.8M | |
Long-Term Debt Repaid | -$46.9M | -$38.7M | -$36.5M | -$53.5M | -$39.1M | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -$4.8M | -$6.9M | -$7.3M | -$7.7M | -$7.8M | |
Cash From Financing | -$37.7M | -$38.3M | -$29.8M | -$60.8M | -$48.1M | |
Beginning Cash (CF) | -- | -- | -- | -- | -- | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $6.6M | $2.3M | $6.2M | -$4M | $2.2M | |
Ending Cash (CF) | -- | -- | -- | -- | -- | |
Levered Free Cash Flow | -- | -- | -- | -- | -- |
Period Ending | 2022-06-30 | 2023-06-30 | 2024-06-30 | 2025-06-30 | 2026-06-30 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -- | -- | -- | -- | -- | |
Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
Stock-Based Compensation | -- | -- | -- | -- | -- | |
Change in Accounts Receivable | -- | -- | -- | -- | -- | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | -- | -- | -- | -- | -- | |
Capital Expenditures | -- | -- | -- | -- | -- | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | -- | -- | -- | -- | -- | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | -- | -- | -- | -- | -- | |
Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -- | -- | -- | -- | -- | |
Cash From Financing | -- | -- | -- | -- | -- | |
Beginning Cash (CF) | -- | -- | -- | -- | -- | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -- | -- | -- | -- | -- | |
Ending Cash (CF) | -- | -- | -- | -- | -- | |
Levered Free Cash Flow | -- | -- | -- | -- | -- |
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.